Opioid Overdose
May 15, 2023
How Decisive Will The OTC Approval of NARCAN Be In The Fight Against The Opioid Epidemic?
On March 29, 2023, the FDA made the landmark decision to approve Emergent BioSolutions’ NARCAN nasal spray for over-the-counter (OTC) and nonprescription use, making it the first naloxone product to be approved for use without a prescription. With about 80,000 fatal opioid overdoses every year, this could potent...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
